| Primary |
| Attention Deficit/hyperactivity Disorder |
50.4% |
| Depression |
8.9% |
| Product Used For Unknown Indication |
5.9% |
| Anxiety |
3.0% |
| Anxiety Disorder |
3.0% |
| Mental Disorder |
3.0% |
| Pain |
3.0% |
| Bipolar Disorder |
2.2% |
| Blood Cholesterol Increased |
2.2% |
| Muscle Spasms |
2.2% |
| Sleep Disorder |
2.2% |
| Thyroid Disorder |
2.2% |
| Abdominal Discomfort |
1.5% |
| Back Injury |
1.5% |
| Disturbance In Attention |
1.5% |
| Fibromyalgia |
1.5% |
| Head Injury |
1.5% |
| Headache |
1.5% |
| Hysterectomy |
1.5% |
| Multiple Sclerosis |
1.5% |
|
| Product Substitution Issue |
20.7% |
| Drug Ineffective |
6.9% |
| Feeling Abnormal |
6.9% |
| Activities Of Daily Living Impaired |
5.2% |
| Anxiety |
5.2% |
| Irritability |
5.2% |
| Product Quality Issue |
5.2% |
| Adrenocortical Insufficiency Acute |
3.4% |
| Blindness |
3.4% |
| Cardiac Arrest |
3.4% |
| Depression |
3.4% |
| Drug Effect Increased |
3.4% |
| Hyperhidrosis |
3.4% |
| Insomnia |
3.4% |
| Nausea |
3.4% |
| Suicidal Ideation |
3.4% |
| Tension |
3.4% |
| Therapeutic Response Unexpected With Drug Substitution |
3.4% |
| Thinking Abnormal |
3.4% |
| Thrombosis |
3.4% |
|
| Secondary |
| Product Used For Unknown Indication |
39.7% |
| Drug Use For Unknown Indication |
19.6% |
| Completed Suicide |
6.1% |
| Attention Deficit/hyperactivity Disorder |
5.4% |
| Depression |
4.2% |
| Pain |
3.7% |
| Muscle Relaxant Therapy |
3.4% |
| Drug Abuse |
3.2% |
| Secondary Progressive Multiple Sclerosis |
2.5% |
| Deep Vein Thrombosis |
1.7% |
| Dyspepsia |
1.7% |
| Fatigue |
1.7% |
| Neuralgia |
1.7% |
| Off Label Use |
1.5% |
| Cataplexy |
1.0% |
| Narcolepsy |
1.0% |
| Crohn's Disease |
0.5% |
| Disturbance In Attention |
0.5% |
| Head Injury |
0.5% |
| Hypertension |
0.5% |
|
| Completed Suicide |
20.0% |
| Toxicity To Various Agents |
10.7% |
| Death |
9.3% |
| Respiratory Arrest |
9.3% |
| Cachexia |
4.0% |
| Cardio-respiratory Arrest |
4.0% |
| Drug Ineffective |
4.0% |
| Hyperhidrosis |
4.0% |
| Intentional Drug Misuse |
4.0% |
| Multiple Drug Overdose |
4.0% |
| Overdose |
4.0% |
| Poisoning |
4.0% |
| Asthenia |
2.7% |
| Irritability |
2.7% |
| Product Substitution Issue |
2.7% |
| Serotonin Syndrome |
2.7% |
| Somnolence |
2.7% |
| Suicidal Ideation |
2.7% |
| Anger |
1.3% |
| Blood Glucose Increased |
1.3% |
|
| Concomitant |
| Pain |
14.2% |
| Product Used For Unknown Indication |
12.9% |
| Depression |
8.8% |
| Contraception |
8.3% |
| Attention Deficit/hyperactivity Disorder |
7.5% |
| Acute Lymphocytic Leukaemia |
6.2% |
| Anxiety |
4.9% |
| Drug Use For Unknown Indication |
4.9% |
| Hypertension |
4.9% |
| Narcolepsy |
3.6% |
| Bipolar Disorder |
3.4% |
| Premenstrual Syndrome |
3.4% |
| Insomnia |
3.1% |
| Multiple Sclerosis |
2.8% |
| Multiple Allergies |
2.1% |
| Polycystic Ovaries |
2.1% |
| Sleep Disorder |
2.1% |
| Cataplexy |
1.8% |
| Bronchitis |
1.6% |
| Chronic Obstructive Pulmonary Disease |
1.6% |
|
| Jaundice |
9.7% |
| Pain |
8.1% |
| Varices Oesophageal |
6.5% |
| White Blood Cell Count Decreased |
6.5% |
| Abdominal Pain |
4.8% |
| Cholecystitis Chronic |
4.8% |
| Diarrhoea |
4.8% |
| Drug Ineffective |
4.8% |
| Injection Site Erythema |
4.8% |
| Myelitis Transverse |
4.8% |
| Nausea |
4.8% |
| Pulmonary Embolism |
4.8% |
| Somnambulism |
4.8% |
| Ventricular Tachycardia |
4.8% |
| Weight Decreased |
4.8% |
| Alopecia |
3.2% |
| Anxiety |
3.2% |
| Cerebrovascular Accident |
3.2% |
| Cholecystitis |
3.2% |
| Gallbladder Disorder |
3.2% |
|
| Interacting |
| Asthma |
50.0% |
| Attention Deficit/hyperactivity Disorder |
50.0% |
|
|
